MIRA Pharmaceuticals Reports Positive Unblinded Phase 1 Data for Ketamir-2

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/21/2026

1. INTC
2. DSX
3. GNK
4. TTEC
5. DAL
6. AWK
7. SPCX
8. III
9. TEVA
10. FCLI

Go back to MIRA Pharmaceuticals Reports Positive Unblinded Phase 1 Data for Ketamir-2
Miracle Applications Corp (NASDAQ: MIRA) Delayed: 0.95 -0.03 (3.06%)
Previous Close $0.98    52 Week High $0.04 
Open $0.96    52 Week Low $0.00 
Day High $0.97    P/E N/A 
Day Low $0.95    EPS $0.00 
Volume 69,672